Aroa Biosurgery is committed to improve healing in complex wounds and soft tissue reconstruction while ‘unlocking regenerative healing for everybody’. AROA ECM™ technology products contain over 150 extracellular matrix (ECM) proteins, enabling interaction with patient’s cells. Aroa delivers high-quality, simple-to-use products that significantly improve outcomes.

AVITA Medical® is a regenerative medicine company leading the development and commercialization of devices and autologous cellular therapies for skin restoration. Our FDA approved RECELL® System technology platform treats patients with thermal burn wounds and full-thickness skin defects.

Cook Biotech Inc. was established in 1995 to develop medical solutions based on the regenerative properties of extracellular matrix materials discovered at Purdue University.

More than 25 years later, our proprietary technologies and manufacturing processes have produced more than 6 million advanced tissue-repair products for global distribution.

We actively seek and welcome partnerships with researchers, distributors, start-up medical companies, and established medical companies to further our mission of serving patients.

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ needs using the latest technologies to develop and deliver innovative biotherapies that are used to treat serious and rare conditions, such as coagulation disorders, primary immune deficiencies, hereditary angioedema and respiratory disease.

The EnVisio system is the first of its kind to combine advanced data capture algorithms and wireless real-time surgical navigation for precision in-site spatial intelligence that guides throughout surgery. VIsit Elucent Medical for more information.

At Ethicon, a Johnson & Johnson MedTech company, putting humanity at the core of care is our passion and our purpose...In collaboration with clinicians and healthcare experts around the world, we develop innovative surgical technologies and solutions to help address some of the most pressing health challenges of our time, such as metabolic disease, cardiovascular disease and cancer.

Pacira BioSciences, Inc. is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

Plasmatica's PLASMA Shield® solves one of the most critical challenges in laparoscopic surgery – maintaining clear visibility throughout a procedure. By creating a super-hydrophilic activated surface on the scope lens, PLASMA Shield® ensures continuous visibility during every laparoscopic procedure without unnecessary interruptions or scope removals, making surgeries safer for the patient and more efficient for the surgical staff.

Takeda